Form 13-F position report

SHOCKWAVE MED INC COM (DE)

Reported by Atika Capital Management LLC

SWAV CUSIP 82489T104 Manager CIK 0001599731

Reported 275,000 shares, down 12,500 (4.3%) from the prior quarter.

Reported value -11.8%; share count -4.3% vs. the prior quarter.

Reduced
% of reported 13F value 5.91% This manager · Q2 2022
Shares 275,000 Quarter-end amount reported
Reported value $52,572,000 Fair value at quarter end
Consecutive quarters held 8 Through Q2 2022

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-09-30 25179000
2021-12-31 22166000
2022-03-31 59616000
2022-06-30 52572000
2022-09-30 36920000
2022-12-31 25206347
2023-03-31 25585940
2023-06-30 33821085
2023-09-30 23195150
2023-12-31 19341840
2024-03-31 37284635
2024-06-30 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

12 quarters
Quarterly reported position history for SHOCKWAVE MED INC COM (DE) held by Atika Capital Management LLC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q2 2024 Reduced 0 -114,500 (-100.0%) 0 $0 2024-08-13
Q1 2024 Added 114,500 +13,000 (12.8%) 3.67% $37,284,635 2024-05-14
Q4 2023 Reduced 101,500 -15,000 (-12.9%) 2.59% $19,341,840 2024-02-13
Q3 2023 Reduced 116,500 -2,000 (-1.7%) 3.04% $23,195,150 2023-11-13
Q2 2023 Added 118,500 +500 (0.4%) 3.39% $33,821,085 2023-08-11
Q1 2023 Reduced 118,000 -4,593 (-3.7%) 3.78% $25,585,940 2023-05-12
Q4 2022 Reduced 122,593 -10,182 (-7.7%) 3.62% $25,206,347 2023-02-13
Q3 2022 Reduced 132,775 -142,225 (-51.7%) 3.13% $36,920,000 2022-11-14
Q2 2022 Reduced 275,000 -12,500 (-4.3%) 5.91% $52,572,000 2022-08-12
Q1 2022 Added 287,500 +163,200 (131.3%) 5.02% $59,616,000 2022-05-13
Q4 2021 Added 124,300 +2,000 (1.6%) 1.56% $22,166,000 2022-02-11
Q3 2021 Added 122,300 +800 (0.7%) 1.5% $25,179,000 2021-11-12
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

366 managers reported SHOCKWAVE MED INC COM (DE) for Q2 2022.

Managers reporting SHOCKWAVE MED INC COM (DE) in Q2 2022.
Manager Activity Shares Change % of reported 13F Reported value Tenure
BlackRock Inc Added 4,313,553 +1,604,775 0.03% $824,622,000 13 qtrs
VANGUARD GROUP INC Added 3,517,666 +206,109 0.02% $672,472,000 14 qtrs
PRICE T ROWE ASSOCIATES INC MD Added 3,214,678 +627,712 0.08% $614,550,000 14 qtrs
FMR LLC Reduced 3,085,338 -7,679 0.06% $589,824,030 14 qtrs
STATE STREET CORPORATION Added 1,125,735 +406,327 0.01% $215,207,000 13 qtrs
JPMorgan Chase & Co Reduced 1,119,608 -52,618 0.03% $214,035,000 14 qtrs
MACQUARIE GROUP LTD Added 1,117,137 +232,570 0.24% $213,563,000 9 qtrs
GILDER GAGNON HOWE & CO LLC Reduced 968,017 -193,142 3.3% $185,056,000 14 qtrs
Artisan Partners Limited Partnership Reduced 697,443 -69,427 0.23% $133,330,000 9 qtrs
GEODE CAPITAL MANAGEMENT LLC Added 634,492 +19,647 0.02% $121,312,000 13 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
June 30, 2022
Filed
August 12, 2022
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
275,000
Shared
0
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.